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ABSTRACT
Macrophages infiltrate cancers and promote progression to invasion and metastasis. To directly examine tumor-
associated macrophages (TAMs) and tumor cells interacting and co-migrating in a three-dimensional (3D) environment, 
we have developed a co-culture model that uses a PyVmT mouse mammary tumor-derived cell line and mouse bone 
marrow-derived macrophages (BMM). The Py8119 cell line was cloned from a spontaneous mammary tumor in a 
Tg(MMTV:LTR-PyVmT) C57Bl/6 mouse and these cells form 3-dimensional (3D) spheroids under conditions of low 
adhesion. Co-cultured BMM infiltrate the Py8119 mammospheres and embedding of the infiltrated mammospheres 
in Matrigel leads to subsequent invasion of both cell types into the surrounding matrix. This physiologically relevant 
co-culture model enables examination of two critical steps in the promotion of invasion and metastasis by BMM: 1) 
macrophage infiltration into the mammosphere and, 2) subsequent invasion of macrophages and tumor cells into the 
matrix. Our methodology allows for quantification of BMM infiltration rates into Py8119 mammospheres and demonstrates 
that subsequent tumor cell invasion is dependent upon the presence of infiltrated macrophages. This method is also 
effective for screening macrophage motility inhibitors. Thus, we have developed a robust 3D in vitro co-culture assay 
that demonstrates a central role for macrophage motility in the promotion of tumor cell invasion.
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BACKGROUND
While 2D cell culture monolayers facilitate examination of intracellular 
signaling cascades and cell behavior, this approach largely ignores the 
more complex structural organization present in the normal physiological 
setting. Cells behave differently in a 3D environment, in part because the 
extracellular matrix is a key regulator of normal homeostasis and tissue 
phenotype [1]. It has long been known that breast epithelial cell lines 
form highly organized, growth arrested acinar structures when grown 
in conditions of low adhesion such as within the basement membrane 
matrix, Matrigel. These mammary organoids are analogous to the 
ductal architecture of normal breast tissue [2]. Examination of cellular 
behavior and signaling using this 3D cell culture approach improves 
the relevance of cell-based assays [3,4]. Non-cancerous human breast 
epithelial cell lines, such as MCF10A, can be induced to become 
invasive upon expression of oncogenes [5]. Similarly, co-culture of 
mammospheres with other cell types such as macrophages can also 
induce invasion [6]. As tumor associated macrophages (TAMs) are key 
players in the regulation of breast cancer metastasis [7,8], the generation 
of mammospheres derived from breast cancer cells and subsequent 
infiltration of the spheroids by macrophages is an attractive model to 
examine mechanisms by which TAMs assist in tumor progression to 
invasion and metastasis.
Macrophages are fully differentiated cells of the mononuclear phago-
cytic lineage and they have coordinated functions in development, tissue 
remodeling and homeostasis. Due to their integrated function with 
parenchymal cells in tissues, macrophages contribute to the pathogen-
esis of a number of chronic diseases [9]. In breast cancer, TAMs have 
been shown to promote tumor invasion and metastasis by establishing 
a paracrine chemotactic loop whereby breast carcinoma cells secrete 
colony stimulating factor-1 (CSF-1) and TAMs secrete epidermal 
growth factor (EGF) to induce co-migration of both cell types [10,11]. 
CSF-1 receptor (CSF-1R) signaling is currently under investigation as 
a therapeutic target [12,13] and we have identified CSF-1-stimulated 
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macrophage motility, through PI3K p110δ and SFKs, as a promising 
specific target to prevent tumor invasion [14-16].
Transwell or collagen overlay assays are standard methods used 
to measure macrophage and tumor cell co-migration [10,15]. A major 
advantage of using mammary spheroid assays over the transwell or 
collagen overlay assays, is that the tumor cells are organized into a 
3D structure, which mimics the pathophysiological development of 
tumors in vivo. In addition, co-culture of macrophages with the mam-
mospheres allows dissection of tumor cell-macrophage interactions in 
the promotion of tumor invasion by macrophages [6]. Despite these 
advantages, this method has been underexploited. Furthermore, the few 
reported assays have either co-cultured human breast cancer cell lines 
with mouse macrophages [17-19] or used human monocyte-derived 
macrophages with a human breast cancer cell line [6]. Co-culture of 
mouse BMM with a mouse mammary tumor-derivettd cell line is both 
species-specific and more experimentally tractable. Thus, we have 
developed a mouse mammary tumor cell-mouse BMM co-culture 
model to examine the role of BMM motility in encouraging tumor cell 
invasion in a more physiologically relevant context. We have chosen 
the Py8119 mammary tumor cell line isolated from a spontaneous 
tumor in a Tg(MMTV:LTR-PyVmT) C57Bl/6 mouse [20] because it 
represents aggressive breast cancer cells that have undergone epithelial 
to mesenchymal transition. Quantitative PCR revealed high levels of 
CSF-1 message in these cells compared with more differentiated lu-
minal breast cancer cells (Fig. 1A). Furthermore, the CSF-1 message 
levels are consistent with the large numbers of macrophages recruited 
in vivo (Fig. 1B). Our in vitro model allows dissection of two critical 
steps involved in the promotion of tumor cell invasion and metastasis 
by BMM; 1) macrophage infiltration into the Py8119 mammosphere, 
and 2) subsequent invasion of co-migrating BMM and tumor cells into 
the surrounding matrix.
The protocol described herein outlines the necessary steps 1) to 
routinely generate Py8119 mammospheres of reproducible size and 
shape, 2) to produce consistent levels of CellTracker Red-labeled 
BMM infiltration into the mammospheres, and 3) to reliably induce 
invasion of tumor cells with their accompanying macrophages into the 
surrounding matrix. Here we show that tumor cell invasion is dependent 
on the presence of infiltrated macrophages. We have recently applied 
this methodology to examine the role of macrophage motility in tumor 
invasion and have shown that the degree of macrophage infiltration into 
Py8119 mammospheres, and the degree of invasion by breast cancer 
cells and macrophages into the matrix is directly proportional to their 
speed of migration (manuscript in preparation).
While we have examined the role of macrophages in a breast cancer 
model, tumor-associated macrophages have been shown to promote 
tumor progression in a wide range of solid tumors [21]. Thus, this or-
ganoid/BMM co-culture system could be extended to other 3D tumor 
models such as pancreatic, prostate and stomach cancer cell line-derived 
organoids [22-26].
Figure 1. CSF-1 expression by PyVmT cell line derived tumors. CSF-1 expression was measured by microarray. A. Spontaneous PyVmT tumors 
-PyVmT T; Py230 well differentiated luminal tumors - Py230 T; and Py8119 aggressive EMT tumors - Py8119 T. Data are means ± SEM from 6 tumors 
per group and were analyzed by one-way ANOVA and Holm-Sidak’s multiple comparisons test. B. Representative sections of PyVmT spontaneous tumor 
and Py230 and Py8119 cell line-derived tumors stained with anti-F4/80, a macrophage marker (brown), and counterstained with hematoxylin (blue).
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MATERIALS
Cells
 9 Py8119 cells isolated from a spontaneous tumor in a Tg(M-
MTV:LTR-PyVmT) C57Bl/6 mouse [20]
 9 Stably transfected EGFP-Py8119 cells (used for live cell 
imaging and flow cytometry)
 9 Mouse bone marrow derived macrophages, isolated from tibiae 
and femurs of C57Bl/6 mice as described previously [16]
Reagents
 9 6-well ultra-low attachment cell culture dish (Corning, cat. 
# 3471)
 9 10 cm Petri cell culture dish (Falcon, cat. # FAL351058)
 9 10 cm Tissue culture treated cell culture dish (Eppendorf, 
cat. # 0030702115)
 9 24-well ultra-low attachment cell culture dish (Corning, cat. 
# 3583)
 9 24-well glass bottom dish (MatTek, cat. # P24G-1.5-10-F)
 9 35 mm Glass bottom dish (MatTek, cat. # P35G-1.5-14-C)
 9 Alexa-488-phalloidin (Life Technologies, cat. # A12379)
 9 ART tips, low retention, 200 µl (Thermo Fisher, cat. # 2069-
05-ART 200P)
 9 B-mercaptoethanol (Sigma Aldrich, cat. # M6250-100 ml)
 9 Bisbenzimide (Hoechst) 33342 (Sigma Aldrich, cat. # B 2261)
 9 Bovine serum albumin (BSA; Sigma Aldrich, cat. # A7906-
100G)
 9 Cell culture medium (a-MEM; Life Technologies, cat. # 
11900-024)
 9 Cell recovery solution (Corning, cat. # 354253)
 9 CellTracker Red CMPTX (Life Technologies, cat. # C34552)
 9 CSF-1; 120 ng/ml (kind gift of E.R. Stanley)
 9 Dulbecco’s phosphate buffered saline, 1x (Life Technologies, 
cat. # 21600-010)
 9 EDTA (0.5 M) (Amresco, USA, cat. # 0322-500G)
 9 FACS tubes, 5 ml round bottom, 12x 75 mm (Falcon, cat. # 
FAL352002)
 9 Fetal calf serum (FCS; Bovogen, cat. # SFBS-F)
 9 Filter tips, 1000 µl (Thermo Fisher, cat. # QSPTF112-1000)
 9 Fungizone (Life Technologies, cat. # 15290018)
 9 Gentamicin (Life Technologies, cat. # 15750078)
 9 Glass coverslips (ProSciTech, cat. # G422)
 9 Glutamax (Life Technologies, cat. # 35050-061)
 9 Glycine (Merck Millipore, cat. # 1042010250)
 9 Goat serum (Life Technologies, cat. # 16210-064)
 9 GS-1101 (Kind gift of Gilead Sciences)
 9 GW2580 (Calbiochem, cat. # 344041)
 9 Ham’s F12K Nutrient Mix (Life Technologies, cat. # 21127022)
 9 L-Asparagine (Sigma Aldrich, cat. # A4159-25G)
 9 Matrigel Basement Membrane Mix, high concentration (HC), 
IdEV-Free (Falcon, cat. # FAL354248)
 9 MITO+™ serum extender (Corning, cat. # 355006)
 9 Paraformaldehyde (32% PFA) (Electron microscopy services, 
cat. # 15714)
 9 Penicillin/Streptomycin (Sigma Aldrich, cat. # P4333)
 9 Prolong Diamond mounting agent with Dapi (Life Technol-
ogies, cat. # P36962)
 9 Sodium hydrogen carbonate, NaHCO
3
 (Fluke, cat. # 71628)
 9 Triton X-100 (Sigma, cat. # T8787-50 ml)
 9 Trizma base (Sigma Aldrich, cat. # T1503)
 9 Trypan blue (BioRad, cat. # 145-0013)
 9 Trypsin (0.25%)/EDTA (2 mM) (Sigma Aldrich, cat. # T 4049)
 9 Tubes, 15 ml, sterile (Thermo Scientific, cat. # 339650)
Recipes
 9 BMM cell culture medium (BMM medium): Add FCS to 10% 
of volume of supplemented α-mem (α-mem, 0.01% (v/v) Pen-
icillin/Streptomycin, 4.4 g NaHCO
3
, 0.005% (v/v) Glutamax, 
40 mg asparagine, 6.8 µl β-mercaptoethanol, pH 7.2) and 120 
ng/ml CSF-1. Store at 4ºC for 4–6 weeks.
 9 Py8119 cell culture medium (Growth medium): To F-12K 
nutrient medium add 5% FCS, 50 µg/ml gentamicin, 2.5 µg/
ml fungizone and 0.1% (v/v) MITO serum extender, and store 
at 4ºC for 4–6 weeks.
 9 2 mM EDTA: Add 200 µl EDTA to 50 ml sterile 1x PBS, filter 
through 0.2 µm filter syringe and store at 4ºC.
 9 Working Matrigel solution: Dilute ultra high concentration 
Matrigel to 8 mg/ml in ice-cold 1 × PBS. Aliquot into 1 ml 
aliquots and store at −20ºC. The solution must be thawed on 
ice for at least 6 h prior to use and kept on ice while pipetting 
since it gels rapidly.
 9 Fix buffer: Add PFA to a final concentration of 2% in 1 × PBS. 
Make fix solution fresh for each experiment.
 9 0.25% Triton X-100: Dilute 10% Triton X-100 in 1 × PBS.
 9 0.1 M glycine: Dissolve 37.5 mg glycine in 5 ml 1 × PBS.
 9 Blocking solution: Prepare a solution containing 1% BSA 
and 10% goat serum to 1 × TBS, adjust pH to 8.0 and store 
at 4ºC. For each experiment, add 1:20 Alexa488-phalloidin 
to the required volume of blocking solution.
 9 Tris-buffered saline: To 800 ml water ad 87.7 g NaCl, 12.1 g 
Trizma base and adjust to pH 7.4
 9 CellTracker Red CMPTX working solution: Prepare a 10 µM 
solution in serum-free media.
 9 FACS buffer: Add FCS to a final concentration of 1% FCS in 
2 mM EDTA in PBS.
Equipment
 9 Cell culture incubator (humidified, 5% CO2)
 9 Biological hood with laminar flow (BH2000 series)
 9 Cell counter (BioRad, cat. # TC10)
 9 Cell counter chamber slides, dual chamber (BioRad, cat. # 
145-0011)
 9 Nikon Eclipse inverted phase microscope (Nikon, cat. # TS-
100)
 9 Eppendorf centrifuge with swing-bucket rotor, refrigerated 
(Eppendorf, cat. # 5804R and cat. # A-4-44 rotor)
 9 A1Si Confocal microscope (Nikon)
 9 BD LSR Fortessa TM SORP 5 lasers (355, 405, 488 (100 m 
Watt), 561, 640 mm), filter set
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PROCEDURE
1. Growing Py8119 cells in 2D
1.1. Grow Py8119 cells on 10 cm tissue culture plates in supplemented F-12K Medium (growth medium).
1.2. Replace growth medium every 1–2 d depending on cell density. Subculture when cells reach 80–90% 
confluency.
2. Establishing Py8119 mammosphere cultures
2.1. Wash Py8119 cells with warm PBS and trypsinize with warm Trypsin/EDTA solution for 3 min at 
37°C. Neutralize with 5 ml cold growth media and count. Pellet by centrifugation at 800 rpm for 5 min.
2.2. Determine the volume required for 2.5 × 104 cells/ml and dilute in growth medium.
2.3. Pipette the desired number of cells into each well of a 6-well ultra-low attachment plate containing 
5 ml growth medium per well.
2.4. Return the plate to the incubator to allow the cells to adhere/aggregate.
2.5. Mammospheres take 25–30 d to grow to approximately 500 µm in diameter (Fig. 2)
2.6. When mammospheres are ready to infiltrate with BMM, gently transfer them in a wide bore tip to 
a 24-well ultra-low attachment dish with one spheroid per well containing 1 ml growth medium to 
ensure each mammosphere is exposed to equal numbers of BMM.
TIPS: (i) Top up the growth medium every 3–4 d. (ii) Manually swirl the plate gently, in a circular motion, 2–3 
times per week to encourage formation of 1–2 mammospheres per well.
CAUTION: Py8119 mammospheres are very fragile and can be disrupted by pipetting. Try to minimize handling 
and, when necessary, use a wide bore tip.
3. Co-culture with BMM
3.1. Culture mature, adherent BMM (3 d post-extraction) in 10 cm Petri dishes in BMM medium as pre-
viously described for 7–10 d prior to infiltration [16].
3.2. Rinse BMM once with warm PBS then stain with 4 ml of 10 µM Cell Tracker Red in serum-free BMM 
medium for 30 min at 37ºC.
3.3. Rinse again with warm PBS and allow to recover in complete BMM medium for at least 1 h prior to 
infiltration.
3.4. Wash cells with warm PBS and incubate with 4 ml 2 mM EDTA for 20 min at 37ºC, then scrape gently 
to lift remaining cells from the dish.
3.5. Count BMM number and dispense 105 cells onto each mammosphere in 100 µl BMM medium.
3.6. Return dish to the incubator (37 ºC, 5% CO2) to allow the macrophages to infiltrate for 3 d.
NOTES: After infiltration, mammospheres can be examined by immuno-fluorescence (step 4) or embedded in 
Matrigel to observe 3D invasion of the ECM (step 5).
4. Immunofluorescent staining of BMM-infiltrated Py8119 mammospheres
4.1. Gently wash BMM-infiltrated mammospheres with 500 µl warm PBS.
4.2. Fix with 2% PFA for 20 min at room temperature.
4.3. Permeabilize with 0.25% Triton X-100 for 10 min at 4°C.
4.4. Wash 1–2 times with 0.1 M glycine for 10 min per wash to remove free aldehydes.
4.5. Block for 60 min in 50 µl 10% goat serum, 1% BSA in 1 × TBS.
4.6. To examine the actin cytoskeleton, add 2.5 µl Alexa-488-conjugated phalloidin to the blocking solution.
4.7. Wash 1–2 times with 1% BSA in 1 × TBS for 5 min.
4.8. Transfer to a MatTek glass bottom dish.
4.9. Mount (e.g. Prolong Diamond with DAPI) and seal with a glass coverslip.
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4.10. Take representative images of BMM-infiltrated mammosphere on a fluorescent microscope, e.g., Nikon 
A1Si Confocal Microscope (Nikon PlanApo 10x objective, numerical aperture 0.45, with differential 
interference contrast (DIC) and 561 nm laser).
4.11. To quantify macrophage infiltration into the spheroid, determine the area of infiltrating macrophages by 
thresholding the Cell Tracker Red signal in IMAGEJ software, and express as a ratio of total spheroid 
area. Correct for BMM number infiltration (%) by loading controls of BMM (6-well dish, not stained), 
using the IMAGEJ cell counter plugin.
TIPS: Use at least three mammospheres per condition for analysis of infiltration.
NOTES: (i) Fixed mammospheres may be stored at 4°C for up to 7 d. (ii) Mount cultures no more than 1 d before 
imaging to prevent accumulation of bubbles in the mounting medium.
5. 3D invasion assay of BMM-infiltrated GFP-Py8119 mammospheres
5.1. Wash BMM-infiltrated mammospheres in PBS and leave on ice while preparing Matrigel coated plate.
5.2. Place 24-well glass bottom plate on ice and coat each well with 50 µl of Matrigel (> 8 mg/ml).
5.3. Transfer plate to incubator and allow the Matrigel to polymerise for 10–15 min.
5.4. Remove the PBS from the mammospheres and gently resuspend in 100 µl of Matrigel and transfer 
immediately to Matrigel-coated plate.
5.5. Return the plate to 37°C for 15 min to polymerise Matrigel, then add 1 ml BMM medium to each well.
5.6. Maintain embedded mammospheres at 37°C, 5% CO2 for 7 d before quantification of cell invasion 
into the Matrigel.
5.7. Obtain brightfield images (e.g., Nikon Eclipse TS-100 microscope) and then using IMAGEJ, calculate 
the maximal distance covered by invasive cells by measuring the difference in mammosphere area 
between d 0 and d 7.
5.8. Live cell imaging can be carried out in a humidified Tokai Hit stage top incubator (37°C, 5% CO2) 
for prolonged periods of up to 3 d. This allows direct observation of motile BMM as they dig tunnels 
through the matrix and interact with tumor cells to encourage their motility (Fig. S1).
5.9. For FACS analysis of invading cells, carefully remove media and replace with 1 ml cell recovery 
solution for 90 min at 4°C.
5.10. Once Matrigel has liquefied, remove only the remaining spheroid mass with a P200 pipette, ensuring 
no extra solution is removed.
5.11. Collect cell recovery solution (minus non-invading spheroid) in microfuge tubes and centrifuge at 
4,000 rpm for 5 min at 4°C to separate the cells from the Matrigel.
5.12. Carefully remove the supernatant and wash the pellet once with FACS buffer and centrifuge to remove 
any remaining Matrigel.
5.13. Resuspend the pellet in 50 µl Hoechst 33342 (5 µg/ml in FACS buffer) and stain for 30 min at 37°C, 
protected from light.
5.14. Wash cells by adding 1 ml FACS buffer and centrifuge at 400 g for 5 min.
5.15. Resuspend cells in 300 µl FACS buffer and analyse by flow cytometry. Our procedure is outlined 
below and shown in Figure S2:
5.15.1. Multicolor flow cytometry was performed on a BD Fortessa LSR SOPR. Cytometry set up and 
tracking beads (Cell Signaling Technology) was performed prior to acquisition after which the 
entire sample (at least 30,000 cells) was acquired under low sample speed.
5.15.2. Compensation was performed as needed.
5.15.3. Data analysis was performed using FlowJo with gating strategies as outlined (Fig. S2).
CAUTION: (i) As Matrigel liquefies at 4°C and solidifies at 37°C, it should be thawed on ice for at least 6 h before 
use. (ii) Pre-cool the 24-well glass bottom dish and P200/1000 pipette tips in the freezer to ensure even spreading 
of Matrigel. (iii) Ensure the entire surface of the glass bottom dish is covered with Matrigel and that no bubbles 
are generated.
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TIPS: Although it is harder to ensure complete coverage of the plate using 50 µl Matrigel, this smaller volume 
improves confocal imaging quality.
NOTES: (i) Matrigel de-polymerizes after 7 d. (ii) CellTracker Red staining fades after 7 d so confocal images 
taken of mammosphere invasion into Matrigel should not be used for quantification by immunofluorescence. (iii) 
Phase contrast images of embedded spheroids should be taken daily from d 0 until the end of the assay at d7. 
Measurement of the invasive area of cells can then be measured by d 7–d 0. (iv) When using inhibitors, the desired 
concentration should be added to the Matrigel used to resuspend the mammospheres and to the BMM medium 
placed on top. Replenish BMM growth medium containing the inhibitors every 2 d. (v) unless fixed prior to flow 
cytometry analysis, transport cells on ice.
ANTICIPATED RESULTS
To optimize Py8119 cell density for the generation of mammospheres, 
we prepared ultra-low attachment 6-well culture plates with 1 × 104, 2.5 
× 104 or 5 × 104 cells/well and observed the formation of aggregates for 
up to 30 d. We determined that 2.5 × 104 cells was the most appropriate 
number to yield spherical mammospheres of approximately 500 µm 
diameter by 20 d of culture (Fig. 2). A higher density of cells produced 
irregular spheroids while a lower density of cells produced much smaller 
spheroids that were harder to handle and more likely to be lost during 
handling (data not shown). Previously, mathematical analysis has shown 
that solid acini above 500 µm in diameter display nutrient-starved 
and necrotic cells within a hypoxic core [3] and therefore our Py8119 
mammospheres mimic the in vivo microenvironment of tumor growth.
As mentioned previously, co-culture of tumor spheroids and mac-
rophages permits separate examination of infiltration of macrophages 
into mammospheres and subsequent co-migration and invasion of 
tumor cells and macrophages into the surrounding matrix. First, we 
investigated the ability of mouse bone marrow-derived macrophages 
(BMM) to infiltrate into the mammospheres. After 3 d, most CellTracker 
Red labeled BMM are found within the outer several layers of tumor 
cells, however occasional BMM can be found deeper within the solid 
Py8119 spheroid (Fig. 3).
We next examined the ability of infiltrated BMM to promote tumor 
cell invasion into the surrounding matrix. Importantly, Py8119 spheroids, 
when embedded into Matrigel in the absence of co-cultured BMM, 
fail to become invasive (Fig. 4A). If BMM are allowed to infiltrate the 
spheroids prior to embedding in Matrigel, invasive activity of Py8119 
cells is activated and they can be seen to co-migrate with BMM away 
from the spheroids and into the Matrigel (Fig. 4A). Rapid quantification 
of the degree of invasion can be carried out by subtracting the starting 
diameter of the spheroid from the final diameter of the invasive area 
after the cells have dispersed widely into the matrix (Fig. 4B). Higher 
power phase contrast imaging suggests that the linear streams of cells 
leaving the mammosphere consists of both BMM and tumor cells (Fig. 
4C), and this was examined further using flow cytometry. After removal 
of the spheroid, flow cytometry of the depolymerized Matrigel was 
carried out to more closely examine the number of invasive tumor cells 
and BMM. The presence of BMM vastly increased the rate of invasion 
with a ratio of invasive tumor cells:invasive BMM of ~2:1 (Fig. 4D). 
Live imaging of invasion soon after embedding revealed the formation 
of tunnels dug by BMM through the Matrigel. The BMM could be seen 
shuttling backwards and forwards in these tunnels (Fig. S1, Movie S1).
Live imaging of Matrigel invasion by CellTracker Red-labeled 
BMM-infiltrated GFP-Py8119 mammospheres confirmed that invasive 
tumor cells were always accompanied by an associated macrophage 
(data not shown). Therefore, any single cells are macrophages.
Figure 2. Py8119 mammosphere formation. Py8119 cells were plated at 2.5 × 104 cells/ml in 6-well ultra-low attachment plates and grown for 20–30 
d before infiltration with BMM. Developing mammospheres were fed with supplemented Ham’s F12K medium every 7 d. Scale bar = 100 µm.
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Figure 4. BMMs promote tumor cell invasion into Matrigel. A. Py8119 mammospheres, either infiltrated with BMM or not, were embedded into Matrigel 
and the area of invasive cells was measured after 7 d. Scale bar = 100 µm. B. Quantification of changes in mammosphere area, including surrounding 
invasive cells is shown, **P < 0.01. C. Phase contrast image (10x magnification) of a live culture BMM-infiltrated mammosphere embedded in Matrigel 
with streams of invading cells. Scale bar = 100 µm. D. Flow cytometric quantification of mammosphere invasion into Matrigel was carried out. Invasive 
EGFP+ Py8119 tumor cells were quantified by flow cytometry after gating for single cells and, in the absence of BMM, only EGFP- was seen (first peak). 
In contrast, large numbers of EGFP+ tumor cells were seen invading the Matrigel from BMM-infiltrated mammospheres (second peak).
Figure 3. BMMs infiltrate 
Py8119 mammospheres. A. 
Py8119 mammospheres were 
infiltrated with BMM (red) for 
3 d. After fixation and staining 
for F-actin (green), and DAPI 
(blue), mammospheres were 
analyzed by Confocal micros-
copy. Scale bar = 100 µm. B. 
Using > 3 mammospheres, the 
degree of infiltration relative to 
mammosphere area was quan-
tified.
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To test our hypothesis that BMM motility regulates tumor cell inva-
sion, we compared the effects of an inhibitor of PI3K p110δ, GS-1101, 
that blocks macrophage motility [14] with a CSF-1R inhibitor, GW2580, 
in our mammosphere co-culture model. Consistent with our hypothesis, 
BMM-infiltrated mammospheres embedded in Matrigel in the presence 
of either GS-1101 or GW2580 failed to invade the surrounding matrix 
(Fig. 5). Since PI3K p110δ is a critical mediator of CSF-1-induced 
macrophage motility, signaling downstream of the CSF-1R is therefore 
integral to the promotion of tumor cell invasion by BMM. Importantly, 
although GW2580 blocks all CSF-1R signaling, this treatment did not 
deplete infiltrating macrophages from the mammosphere co-cultures 
(data not shown). Furthermore, as PI3K p110 is only expressed in he-
matopoietic cells such as macrophages, and not tumor cells, GS-1101 
specifically targets macrophages in this context [14].
In summary, this robust co-culture system can be used to analyze 
BMM promotion of tumor cell invasion and screening for druggable 
targets. It is a useful tool to further dissect the mechanisms of promotion 
of tumor metastasis by macrophages.
Figure 5. Inhibition of BMM motility blocks tumor cell invasion. A. Representative images of macrophage-infiltrated Py8119 mammospheres em-
bedded in Matrigel in the presence of DMSO, CSF-1R inhibitor (GW2580; 2 µM) or PI3K p110δ inhibitor (GS-1101; 2 µM). After 7 d, the area of invasive 
cells was quantified for at least 3 mammospheres per condition. Scale bar = 100 µm. B. Quantification of tumor cell invasion. ***P < 0.001, **P < 0.01.
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TROUBLESHOOTING Tips for troubleshooting can be found in Table 1.
Table 1. Troubleshooting.
Step Problem Possible reason Solution
2.4 Mammospheres do 
not form spherical 
shapes or take >30 
d to form
• Cell density is too high
• Cell density is too low
• Py8119 cells were allowed to 
get too dense in 2D culture
• Optimize cell number
• Manually swirl plate after 14 d in culture to encourage aggregation
• Replenish growth medium with 2 ml every 4 d
• Don’t allow Py8119 2D culture to become confluent prior to establishing 3D 
cultures
2.5 Mammosphere 
structure is disrupt-
ed during transfer
• Pipette tip is too narrow
• Mammosphere was not trans-
ferred carefully
• Use a wide bore pipette tip or cut the end off a tip with a sharp, sterile scalpel
• Pipette mammosphere slowly and evenly
• Allow mammosphere to sink to the bottom of the tip before ejecting
4.7 No/very little mac-
rophage infiltration
• CellTracker Red staining is too 
faint
• Number of macrophages used 
to infiltrate is too few
• If staining a very dense plate of macrophages, leave CTR solution on the cells 
for 35–40 min
• Increase concentration of CTR (NOTE: (i) Stock CTR is made up in DMSO, 
which is toxic to the cells at high concentrations. (ii) If a higher concentration of 
CTR is used, ensure the cells are allowed to recover for 3–4 h)
• Increase macrophage number
• Avoid scraping BMM too hard when lifting in EDTA
5.2 Matrigel layer con-
tains air bubbles
• Pipette tip contained air while 
pipetting
• Matrigel was not thawed com-
pletely
• Ensure pipette tips are pre-cooled at −20°C prior to use
• Use tips with a wider diameter or cut the tip with a sterile scalpel
• Allow Matrigel to thaw on ice at 4ºC for at least 6 h
5.2 Matrigel is not 
evenly distributed 
in wells
• Matrigel was not added slowly 
and evenly to wells
• Matrigel was not thawed com-
pletely
• Ensure glass-bottom 24-well plate is pre-cooled at −20ºC prior to use and 
perform all steps on ice
• Mix Matrigel by swirling the tube before each pipetting step and pipette the solu-
tion slowly and evenly into the centre of the wells
• Swirl the plate to ensure even distribution of Matrigel
• Allow Matrigel to thaw on ice at 4ºC for at least 6 h
5.3 Matrigel is not 
polymerizing
• Concentration of Matrigel is 
too low
• Use non-GFR Matrigel (high concentration) diluted to ≥ 8 mg/ml
5.5 Matrigel appears 
collapsed or 
retracted
• Medium was added too fast or 
with too much pressure
• Plate was agitated
• Make sure medium is added very carefully
• Don’t remove the plate from the incubator for more than 5 min (except where 
necessary)
• Transport and handle the plate carefully
5.7 Cells are not invad-
ing the surrounding 
Matrigel
• Macrophage cell number is too 
low
• Matrigel concentration is too 
low
• Growth factor reduced (GFR) 
Matrigel is used
• Increase number of infiltrating macrophages
• Use non-GFR Matrigel with a concentration ≥ 8 mg/ml
• Replenish media every 2 d
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Supplemental information
Figure S1. BMM-infiltrated Py8119 mammospheres were embedded 
in Matrigel for 3 d then subjected to live imaging by confocal micros-
copy for another 3 d (Nikon A1Si Confocal Microscope, Apo Plan 10x 
objective, NA 0.45, 6.85µm z-steps every 30 min). 
Figure S2. Cells were gated in FSC-Area versus SSC-Area, after 
which FSA-Area versus FSC-Height was used to identify single cells. 
Movie 1. BMM-infiltrated mammospheres were embedded in Matri-
gel for 3 d then imaged live by confocal microscopy for another 3 d 
(Nikon A1Si Confocal Microscope, Apo Plan 10x objective, NA 0.45, 
6.85 µm z-steps every 30 min). 
Supplementary information of this article can be found online at 
http://www.jbmethods.org/jbm/rt/suppFiles/132.
